The latest Healthtech M&A Market Report from international technology mergers and acquisitions adviser Hampleton Partners, show a final count of almost 100 deals took place in the healthtech sector in the second half of 2018.
Transaction volume remained steady compared to the first half of 2018, inching down by a mere 6 per cent and thus remaining in line with a remarkably stable trend since 2013. The trailing 30-month revenue multiple rose again to 2.8x EV/S, prolonging a trend visible over the last 18 months.
In 2018, 186 healthcare companies went public, bringing aggregate gross IPO proceeds for the year to $24bn, up from only $15bn in 2017.
Largest healthtech transactions
The largest disclosed deals in the second half of 2018 included Veritas Capital and Evergreen Coast Capital’s joint private equity acquisition of athenahealth for $5.7bn, at 17.3x EV/EBITDA. Athenahealth provides electronic healthcare record management SaaS for hospitals and healthcare practices in the U.S....